第 1 到 12 筆結果,共 12 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2019 | CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells | Lin H.-W.; YING-CHENG CHIANG ; Sun N.-Y.; YU-LI CHEN ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 14 | 13 | |
2 | 2019 | Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization | Sun N.-Y.; YU-LI CHEN ; Wu W.-Y.; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancers | 39 | 38 | |
3 | 2019 | BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes | YU-LI CHEN ; Lin H.-W.; CHUNG-LIANG CHIEN ; YEN-LING LAI ; WEI-ZEN SUN ; CHI-AN CHEN ; WEN-FANG CHENG | Journal for ImmunoTherapy of Cancer | 66 | 48 | |
4 | 2019 | Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes | Sun N.-Y.; U-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEI-ZEN SUN ; CHUNG-LIANG CHIEN ; WEN-FANG CHENG | Cancer Letters | 12 | 13 | |
5 | 2019 | mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment | YU-LI CHEN ; Lin H.-W.; Sun N.-Y.; JR-CHI YIE ; Hung H.-C.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancers | 11 | 11 | |
6 | 2018 | Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment | Chang M.-C.; YU-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; Hsieh S.-F.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Molecular Therapy | 31 | 28 | |
7 | 2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 32 | 29 | |
8 | 2015 | IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients | YU-LI CHEN ; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 11 | 8 | |
9 | 2013 | Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma | YU-LI CHEN ; WEN-FANG CHENG ; Chang M.-C.; Lin H.-W.; Huang C.-T.; CHUNG-LIANG CHIEN ; CHI-AN CHEN | Gynecologic Oncology | 20 | 16 | |
10 | 2012 | Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways | Chang M.-C.; CHI-AN CHEN ; Chen P.-J.; YING-CHENG CHIANG ; YU-LI CHEN ; TSUI-LIEN MAO ; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG | Biochemical Journal | 113 | 112 | |
11 | 2012 | Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses | YU-LI CHEN ; Chang M.-C.; CHI-AN CHEN ; Lin H.-W.; WEN-FANG CHENG ; CHUNG-LIANG CHIEN | PLoS ONE | 34 | 29 | |
12 | 2012 | Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response | YU-LI CHEN ; Chang M.-C.; Huang C.-Y.; YING-CHENG CHIANG ; Lin H.-W.; CHI-AN CHEN ; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Oncology | 107 | 103 |